Feature Channels
Surgery
Filters:
MedicineChannels:Keywords: |
EMBARGOEDA reporter's PressPass is required to access this story until the embargo expires on 6/19/2013 5:00 PM EDT |
6/19/2013 5:00 PM EDT
Released to reporters: 6/18/2013 1:05 PM EDT
|
MedicineChannels:Keywords: |
EMBARGOEDA reporter's PressPass is required to access this story until the embargo expires on 6/19/2013 8:00 AM EDT |
6/19/2013 8:00 AM EDT
Released to reporters: 6/18/2013 8:00 AM EDT
|
MedicineChannels:Keywords: |
The Facebook Effect: Social Media Dramatically Boosts Organ Donor RegistrationA social media push boosted the number of people who registered themselves as organ donors 21-fold in a single day, Johns Hopkins researchers found, suggesting social media might be an effective tool to address the stubborn organ shortage in the United States. |
Embargo expired: 6/18/2013 12:05 AM EDT
Released: 6/14/2013 2:40 PM EDT
Johns Hopkins Medicine |
MedicineChannels:Keywords: |
New Alternative to Surgery Lets Doctors Remove Suspicious Polyps, Keep Colon IntactA UCLA team of surgeons and gastroenterologists has been performing a new, minimally invasive procedure to remove large and hard-to-reach polyps while keeping the colon intact. The procedure, which combines two minimally invasive techniques, has currently been performed at only a handful of medical centers in the United States. |
Released: 6/17/2013 11:00 AM EDT
University of California, Los Angeles (UCLA), Health Sciences |
MedicineChannels:Keywords: |
Testosterone Therapy Improves Sexual Function After Uterus and Ovary RemovalHigh doses of testosterone significantly improve sexual function among women who have had their uterus and ovaries surgically removed, a clinical study demonstrates. The results were presented Sunday at The Endocrine Society’s 95th Annual Meeting in San Francisco. |
Released: 6/16/2013 3:45 PM EDT
Endocrine Society |
MedicineChannels:Keywords: |
Differences in Outcomes of Cervical Spine Surgery at Teaching versus Non-Teaching HospitalsFor patients undergoing surgery on the cervical (upper) spine, overall rates of complications and death are higher at teaching hospitals than at non-teaching hospitals, reports a study in the June 1 issue of Spine. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health. |
Released: 6/12/2013 11:00 AM EDT
Wolters Kluwer Health: Lippincott Williams & Wilkins |
MedicineChannels:Keywords: |
Study Assesses Impact of Rheumatoid Arthritis on Joint Replacement Surgery OutcomesTwo new studies by researchers at Hospital for Special Surgery have shed light on joint replacement outcomes in patients with rheumatoid arthritis (RA). |
Embargo expired: 6/12/2013 12:05 AM EDT
Released: 6/11/2013 5:00 PM EDT
Hospital for Special Surgery |
MedicineChannels:Keywords: |
New Surgical Technique for Bell's Palsy Facial Paralysis
A Loyola University Medical Center surgeon is using electrical stimulation as part of an advanced surgical technique to treat Bell’s palsy, a condition that causes paralysis on one side of a patient’s face. |
Released: 6/11/2013 4:25 PM EDT
Loyola University Health System |
MedicineChannels:Keywords: |
Transplant Patient Outcomes After Trauma Better Than ExpectedIn the largest study of its kind, Baltimore researchers find that traumatic injury outcomes in patients with organ transplants are not worse than for non-transplanted patients, despite common presumptions among physicians. Additionally, transplanted organs are rarely injured in traumatic events. |
Released: 6/10/2013 11:50 AM EDT
University of Maryland Medical Center |
MedicineChannels:Keywords: |
Surgeons at Duke University Hospital Implant Bioengineered VeinIn a first-of-its-kind operation in the United States, a team of doctors at Duke University Hospital helped create a bioengineered blood vessel and implanted it into the arm of a patient with end-stage kidney disease. The procedure, the first U.S. clinical trial to test the safety and effectiveness of the bioengineered blood vessel, is a milestone in the field of tissue engineering. The new vein is an off-the-shelf, human cell-based product with no biological properties that would cause organ rejection. |
Released: 6/6/2013 9:35 AM EDT
Duke Medicine |
